Every pharmacist eventually faces the same crossroads: continue practising indefinitely, bring in successors, or sell the practice and transition into the next stage of life. Whether the goal is retirement, sale, or inter-generational transfer, a succession plan is the bridge between professional success and personal legacy. Without one, the value of a pharmacy can evaporate through taxation, poor timing, or regulatory oversight.
A pharmacy is unusual: it is both a regulated health-care enterprise and a valuable private corporation. Its goodwill depends on professional competence, patient trust, and continuous licence compliance. A succession plan answers four essential questions — who will own and operate the pharmacy after you retire or die; how will the transition occur (sale, share transfer, or merger); what tax consequences will arise and how can they be minimized; and how will your patients, employees, and regulators experience continuity. Without clear answers, even a profitable pharmacy can lose a large part of its value within months of an unplanned departure.
Start with what the pharmacy is worth
Before restructuring anything, determine what the pharmacy is worth and what drives that value. Pharmacy valuation turns on prescription-file value and patient count (the lifeblood of goodwill), normalized earnings (gross margins and EBITDA), inventory and working capital (adjusted for expired or slow-moving stock), the leasehold and location (a long-term, assignable lease adds value), staff and systems (retention of key pharmacists and stable technology), and compliance history (the absence of College or Health Canada citations).
The valuation matters for tax, not just for negotiation. It establishes the fair-market value (FMV) used for any share exchange, rollover, or sale; it determines whether gains are capital or income; and it determines whether the Lifetime Capital Gains Exemption (LCGE) can be claimed.
The two-corporation foundation: PPC and Holdco
Most practising pharmacists operate through a Pharmacy Professional Corporation (PPC) owned, in turn, by a Holding Company (Holdco). Each entity has a job. The PPC conducts active pharmacy operations and is eligible for the small-business rate and the LCGE if it is purified. The Holdco receives dividends, holds surplus cash, real estate, and insurance, isolates risk, and accumulates investments. A family trust, where one is used, holds growth shares for a spouse and children to multiply the LCGE and to facilitate an estate freeze.
The reorganization goals follow from that structure: tax deferral and flexibility (section 85 rollovers to move assets without immediate tax), income splitting and estate freezes (shifting future growth to family or a trust), asset protection (isolating passive assets in the Holdco), sale readiness (positioning the corporation for the LCGE and due diligence), and succession continuity (so pharmacist heirs or partners can step in smoothly).
The section 85 rollover
A section 85(1) election under the Income Tax Act allows a taxpayer to transfer assets to a corporation in exchange for shares on a tax-deferred basis. Pharmacists use it to incorporate a sole proprietorship, to transfer real estate, equipment, or goodwill to a Holdco, and to reorganize share classes in preparation for an estate freeze. The key documents are a transfer agreement (bill of sale or asset-transfer agreement), a directors' resolution authorizing issuance of shares, and Form T2057 filed with the CRA within the prescribed time. In a typical example, a pharmacist transfers an unincorporated practice valued at $600,000 to a new PPC in exchange for preferred and common shares; no tax is triggered, and the new corporation inherits the original cost base. The mechanics are covered in more depth on our section 85 rollover page.
Purification and QSBC status
To claim the LCGE — $1.25 million per individual on QSBC shares as of 2025 — a corporation must satisfy the Qualified Small Business Corporation (QSBC) tests: at least 90% of the FMV of its assets must be used in an active business at the time of sale or death; the shares must have been held by you or related persons for 24 months; and throughout those 24 months more than 50% of the corporation's assets must have been used in active business. Corporations accumulate cash and passive assets over time, which is why purification — transferring excess cash and investments to the Holdco, paying dividends or bonuses to reduce retained earnings, selling passive real estate or non-operating assets, and moving corporate-owned life insurance to the Holdco — is so often required. Begin purification at least 24 months before a sale or expected death to satisfy the holding-period test.
The estate freeze
An estate freeze locks in the current value of your shares and transfers future growth to the next generation or a family trust. It caps the taxable value of your estate, lets children or trust beneficiaries benefit from future appreciation, and multiplies use of the LCGE. The mechanics are to exchange existing common shares for fixed-value preferred shares equal to FMV, issue new common shares to children or a trust for nominal value, and file the section 86 or 51 elections where required. One professional caution dominates the pharmacy context: only licensed pharmacists may hold voting shares in the PPC, so the trust or non-pharmacist family members must hold non-voting shares unless the College permits otherwise. Our estate freeze guide walks through the structure in detail.
The Holdco's role in passive-asset management
A Holdco is central to both risk management and tax efficiency. It protects surplus cash from professional liability, receives tax-free inter-corporate dividends from the PPC, holds corporate-owned life insurance without tainting the PPC's QSBC status, and facilitates family investment management. Two cautions apply: keep loan accounts documented to avoid shareholder-benefit assessments, and avoid accumulating passive income above $50,000 per year, which reduces the small-business deduction limit.
Buy-sell agreements where partners co-own
When partners co-own a pharmacy, a buy-sell agreement prevents future conflict. Its core clauses set out the triggering events (death, disability, retirement), the valuation method (FMV by independent appraiser), funding through life insurance, a right of first refusal or shot-gun mechanism, and non-competition and confidentiality provisions. Transparency with partners and a clear valuation formula prevent litigation and protect staff and patients during ownership transitions.
Selling: asset versus share
The single most important structural decision in a sale is whether to sell assets or shares. In an asset sale the purchaser buys inventory, fixtures, and goodwill; the CRA treats the proceeds as business income and recapture; the vendor cannot use the LCGE. In a share sale the purchaser buys the shares of the PPC; the vendor can claim the LCGE on the capital gain; there is no need to transfer licences if ownership remains pharmacist-controlled; but the corporation has to be clean and purified. The practical recommendation in the book is to structure the corporation so a share sale is feasible — you can always restructure for an asset sale later if a buyer insists. We cover the trade-offs in our guide to selling a pharmacy.
Tax planning for sale or retirement
Several levers reduce tax on exit. The LCGE shelters up to $1.25 million of gain on QSBC shares per eligible individual, and a family trust can multiply this across a spouse and children. A capital-gains reserve under subparagraph 40(1)(a)(iii) can spread the gain over up to five years where proceeds are received over several years. A vendor take-back loan defers part of the gain and earns interest, and should be backed by security agreements to protect against default. Pipeline planning avoids double taxation on death by converting corporate retained earnings into a capital repayment rather than a taxable dividend. And donating publicly traded shares or cash from the proceeds can offset final-year taxes while honouring a legacy in the profession.
Succession to children or junior partners
Transferring ownership internally requires balancing tax efficiency, fairness, and professional eligibility. The intergenerational-business-transfer rules (originating with Bill C-208) permit a tax-deferred sale of shares to a child's corporation where the child controls the purchasing corporation, the shares are held for a minimum period, and the vendor ceases to control the business. A family-trust approach allows growth to be allocated to children while control is maintained through trusteeship. A gradual transfer over two to five years, documented through employment and shareholder agreements, maintains patient continuity and reduces risk.
A worked illustration
The book's illustrative case follows a pharmacist whose practice is worth $2.4 million and whose daughter is a licensed pharmacist working in the business. The owner carries out an estate freeze at the $2.4 million FMV, issuing new growth shares to a family trust; the Holdco buys corporate-owned insurance to fund tax on death; after a holding period the daughter's corporation buys her mother's preferred shares under the intergenerational rules; the mother claims the LCGE and retires on $1.25 million of gain that is sheltered; and the daughter continues operations seamlessly. The modelled tax saving is roughly $325,000, with family harmony and regulatory compliance preserved.
A pharmacy is more than a storefront — it is the tangible expression of years of study, patient relationships, and community trust. A deliberate succession and reorganization strategy, built on sound legal drafting, disciplined purification, family-trust planning, and ethical transparency, converts the practice from a personal enterprise into an enduring legacy. Succession planning is not the end of a professional story; it is the final act of responsible practice management.
This guide draws on Dale Barrett's book "Tax-Wise Estate Planning for Pharmacists" (Barrett Publishing). It is general information about Canadian tax and estate-planning concepts, not legal, tax, or accounting advice; pharmacy ownership rules vary by province and by College, so confirm the current rules and obtain professional advice before acting.